Jeremy Udkoff
MOHS-Micrographic Surgery · Mt Lebanon, PANPI 1447756499
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $577 of the $657 with a category attached, or 87.8%. 9 manufacturers reported payments, led by Revance Therapeutics, Inc. at 41.7% of the total. 2025 is the largest year on record at $484, 5.2 times the $94 reported in 2022. That places this record below the midpoint for mohs-micrographic surgery clinicians in PA, where the typical reported total is $1,161.
Across 20 payments — averaging $32.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Revance Therapeutics, Inc.$274
- Regeneron Healthcare Solutions, Inc.$94
- Johnson & Johnson$80
- Sun Pharmaceutical Industries Inc.$70
- Amgen$54
- Novartis$29
- plus $57 from 3 others
What the payments were for
- Food & beverage$57788%
- Education$8012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Revance Therapeutics, Inc. | 9 | $274 |
| Regeneron Healthcare Solutions, Inc. | 1 | $94 |
| Johnson & Johnson | 1 | $80 |
| Sun Pharmaceutical Industries Inc. | 2 | $70 |
| Amgen | 3 | $54 |
| Novartis | 1 | $29 |
| Smith+Nephew | 1 | $21 |
| Merz North America, Inc. | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
How this compares
$657 in reported general payments places this provider in the 30th percentile of 48 mohs-micrographic surgery providers in Pennsylvania.
See all mohs-micrographic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 11 | $1,229 |
| Triamcinolone Acetonide | 44 | $450 |
| Cephalexin | 90 | $370 |
| Ketoconazole | 23 | $228 |
| Mupirocin | 26 | $176 |
| Doxycycline Monohydrate | 12 | $106 |
| Doxycycline Hyclate | 13 | $84 |
| Hydrocortisone | 15 | $71 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Mt Lebanon
- Gregory FulchieroAltoona$24K
- Jason SchoenfeldPhiladelphia$20K
- Cynthia BartusAllentown$10K
- Ernest BenedettoPhiladelphia$9K
- Carmen CampanelliYardley$8K
- Aradhna SaxenaFort Washington$8K
- Nicole VelezCranberry Township$6K
- Justin VujevichPittsburgh$6K
- Preetha AgarwalPittsburgh$6K
- Julian NgoCarlisle$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.